Abstract 3226: The IRF8-osteopontin-CD44 axis functions as an immune checkpoint to control CD8+ T cell activation and tumor immune evasion

2019 ◽  
Author(s):  
John D. Klement ◽  
Amy V. Paschall ◽  
Priscilla S. Redd ◽  
Mohammed L. Ibrahim ◽  
Chunwan Lu ◽  
...  
Keyword(s):  
T Cell ◽  
T Cell Activation ◽  
Immune Evasion ◽  
Immune Checkpoint ◽  
Cell Activation ◽  
Cd8 T Cell ◽  
Tumor Immune Evasion

scholarly journals An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion

2018 ◽  
Vol 128 (12) ◽  
pp. 5549-5560 ◽  
Author(s):  
John D. Klement ◽  
Amy V. Paschall ◽  
Priscilla S. Redd ◽  
Mohammed L. Ibrahim ◽  
Chunwan Lu ◽  
...  
Keyword(s):  
T Cell ◽  
T Cell Activation ◽  
Immune Evasion ◽  
Immune Checkpoint ◽  
Cell Activation ◽  
Cd8 T Cell ◽  
Tumor Immune Evasion

Abstract 3226: The IRF8-osteopontin-CD44 axis functions as an immune checkpoint to control CD8+ T cell activation and tumor immune evasion

2019 ◽  
Author(s):  
John D. Klement ◽  
Amy V. Paschall ◽  
Priscilla S. Redd ◽  
Mohammed L. Ibrahim ◽  
Chunwan Lu ◽  
...  
Keyword(s):  
T Cell ◽  
T Cell Activation ◽  
Immune Evasion ◽  
Immune Checkpoint ◽  
Cell Activation ◽  
Cd8 T Cell ◽  
Tumor Immune Evasion

T-cell Activation Induces Dynamic Changes in miRNA Expression Patterns in CD4 and CD8 T-cell Subsets

MicroRNA ◽  
2015 ◽  
Vol 4 (2) ◽  
pp. 117-122 ◽  
Author(s):  
Nato Teteloshvili ◽  
Katarzyna Smigielska-Czepiel ◽  
Bart-Jan Kroesen ◽  
Elisabeth Brouwer ◽  
Joost Kluiver ◽  
...  
Keyword(s):  
T Cell ◽  
T Cell Activation ◽  
Mirna Expression ◽  
Cell Activation ◽  
Expression Patterns ◽  
Cd8 T Cell ◽  
T Cell Subsets ◽  
Dynamic Changes

Alterations in STAT Signaling Dysregulate CD8 T Cell Activation

2021 ◽  
Vol 147 (2) ◽  
pp. AB151
Author(s):  
Jose Campos ◽  
Peyton Conrey ◽  
Samir Sayed ◽  
Tiphanie Vogel ◽  
Jennifer Leiding ◽  
...  
Keyword(s):  
T Cell ◽  
T Cell Activation ◽  
Cell Activation ◽  
Cd8 T Cell ◽  
Stat Signaling

CD8 T cell activation after intravenous administration of CD3×CD19 bispecific antibody in patients with non-Hodgkin lymphoma

1995 ◽  
Vol 40 (6) ◽  
pp. 390-396 ◽  
Author(s):  
Gijsbert C. de Gast ◽  
Inez-Anne Haagen ◽  
Anja A. van Houten ◽  
Sigrid C. Klein ◽  
Ashley J. Duits ◽  
...  
Keyword(s):  
T Cell ◽  
Hodgkin Lymphoma ◽  
T Cell Activation ◽  
Intravenous Administration ◽  
Cell Activation ◽  
Bispecific Antibody ◽  
Cd8 T Cell ◽  
Non Hodgkin Lymphoma

Efficiency and Mechanism of Antigen-specific CD8+ T-cell Activation Using Synthetic Long Peptides

2012 ◽  
Vol 35 (2) ◽  
pp. 142-153 ◽  
Author(s):  
Maarten L. Zandvliet ◽  
Michel G. D. Kester ◽  
Ellis van Liempt ◽  
Arnoud H. de Ru ◽  
Peter A. van Veelen ◽  
...  
Keyword(s):  
T Cell ◽  
T Cell Activation ◽  
Cell Activation ◽  
Cd8 T Cell ◽  
Synthetic Long Peptides

scholarly journals Factors Associated With CD8+ T-Cell Activation in HIV-1–Infected Patients on Long-term Antiretroviral Therapy

2014 ◽  
Vol 67 (2) ◽  
pp. 153-160 ◽  
Author(s):  
Lu Zheng ◽  
Babafemi Taiwo ◽  
Rajesh T. Gandhi ◽  
Peter W. Hunt ◽  
Ann C. Collier ◽  
...  
Keyword(s):  
T Cell ◽  
Antiretroviral Therapy ◽  
T Cell Activation ◽  
Cell Activation ◽  
Cd8 T Cell ◽  
Factors Associated ◽  
Hiv 1
Sign in / Sign up

Export Citation Format

Share Document